Robert Odendi Gideon
ID: UNCST-2024-R002130
|
MENTAL HEALTH CHALLENGES, ADVERSE CHILDHOOD EXPERIENCES
AND INTERPERSONAL PSYCHOTHERAPY AMONG ADOLESCENTS AT KAMPIRINGISA
NATIONAL REHABILITATION CENTER, CENTRAL UGANDA
REFNo: HS5763ES
1. To determine the prevalence of mental health challenges (Depression, PTSD, and alcohol substance use disorders) and adverse childhood experiences (ACEs) among adolescents at Kampiringisa National Rehabilitation Centre (KNRC).
2. To examine the relationship between ACEs and mental health challenges, with social support as a mediator among adolescents at KNRC.
3. To explore the experiences and perceptions of adolescents regarding the effectiveness of existing counseling practices in reducing depressive symptoms among adolescents at KNRC.
4. To identify the socio-cultural factors, institutional policies, and individual characteristics that influence the feasibility, acceptability, and effectiveness of Group Interpersonal Therapy (Group IPT) in reducing depressive symptoms at KNRC.
5. To evaluate adolescents' experiences and perceptions of the feasibility, acceptability, and effectiveness of Group IPT compared to the existing counseling practices at KNRC.
|
Uganda |
2025-04-02 10:00:01 |
2028-04-02 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
Felix Bongomin
ID: UNCST-2020-R014224
|
Chronic Pulmonary Aspergillosis: Optimization of Therapy, Immunogenetic Screening, and Diagnosis in Uganda [CPA_OPTIONS_Phase I: A Prospective Cohort Study]
REFNo: HS5799ES
The primary objective of this study is to establish a longitudinal cohort comprising individuals who have recently been diagnosed with CPA. The main aim is to comprehensively document various aspects of the disease progression and its impact on patients\' health over a span of 12 months.,The primary objective of this study is to establish a longitudinal cohort comprising individuals who have recently been diagnosed with CPA. The main aim is to comprehensively document various aspects of the disease progression and its impact on patients\' health over a span of 12 months.,
|
Uganda |
2025-04-01 17:44:43 |
2028-04-01 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
Stella Muyanja Zawedde
ID: UNCST-2021-R014037
|
The Integrated Management of Chronic Lung Illnesses in Uganda
REFNo: HS5728ES
Aim 1: To determine the prevalence of and factors associated with chronic respiratory illnesses e.g., asthma, chronic obstructive pulmonary disease among presumptive TB patients who test negative for TB on GeneXpert testing
Aim 2: (a) To determine the prevalence of, factors associated with post TB lung disease (PTLD) among patients who complete TB treatment (b) To determine the effect of post TB lung care on health related QoL among patients with PTLD
Aim 3: To determine barriers and facilitators for linkage to treatment for patients referred for chronic lung care
Aim 4: To document the cost per asthma/COPD case found during integrated community-based screening.
|
Uganda |
2025-04-01 17:31:43 |
2028-04-01 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
george paasi
ID: UNCST-2020-R014619
|
THE CLINICAL SPECTRUM, GEOSPATIAL DISTRIBUTION AND GENETIC MODIFIERS OF SEVERE MALARIA AMONG CHILDREN WITH SICKLE CELL DISEASE IN EASTERN UGANDA.
REFNo: HS5714ES
i) To determine the effect of host RBC polymorphisms on the risk and severity of malaria.
ii) To determine the Geospatio-temporal distribution of the malaria-sickle cell disease syndemic in Uganda.
iii) To determine the clinical spectrum of severe malaria among children with SCA in eastern Uganda.
|
Uganda |
2025-04-01 17:21:57 |
2028-04-01 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
.jpg)
|
ERICK SSEGUJJA
ID: UNCST-2021-R012964
|
Partnerships for Stronger Knowledge Systems in Africa (KNOSA): Lessons from Uganda
REFNo: HS5716ES
Specifically, the implementation research has the following objectives;
1. To characterise the nature and functioning of the different components of the current national knowledge system, ??with a focus on the health sector.
2. To explore constraints and challenges affecting the capacity of Uganda’s national knowledge systems.
3. To document and assess the current interventions to strengthen the national knowledge system?
4. To explore opportunities for strengthening the capacity of the national knowledge system to advance evidence-informed decision making in Uganda’s health sector.
|
Uganda |
2025-03-25 11:14:05 |
2028-03-25 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
.JPG)
|
Ronald Moses Galiwango
ID: UNCST-2024-R015239
|
INTEGRATED FEMALE SEXUALLY TRANSMITTED INFECTION TESTING FOR HIV EPIDEMIC CONTROL THROUGH PREP (IN-STEP)
REFNo: HS5715ES
a) To conduct an individually randomized effectiveness implementation trial of SRST plus cSTI testing to increase PrEP use among African women at high HIV risk.
b) To perform a mixed-methods, implementation science evaluation of female cSTI testing for improving PrEP use for HIV prevention.
c) To determine the most efficient, population-level female cSTI testing strategies to reduce HIV incidence in African settings.
|
Uganda |
2025-03-25 11:13:20 |
2028-03-25 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Prudence Beinamaryo
ID: UNCST-2023-R007239
|
Developing a robust interdisciplinary-informed WASH framework for the prevention and elimination of the wicked public-health problem of schistosomiasis (WickedSchisto)
REFNo: HS5707ES
I. What are the true health, economic and societal impacts of schistosomiasis?
a) Characterise what quality of life means to individuals living in Schistosoma endemic areas in Cameroon and Uganda, and how this is affected by infections, WASH access, environmental, spatial, social and other determinants.
b) Measure the diverse impact of schistosomiasis on individual’s and household’s quality of life.
c) Quantify the economic costs associated with schistosomiasis to individuals and society.
d) Develop and validate a field-suitable morbidity marker for mapping and monitoring disease resolution.
II. What are the most cost-effective combinations of WASH and MDA interventions?
a) Test the hypothesis that MDA refusal, due to fear of side effects, is linked with latrine access.
b) Characterise relative contributions of existing WASH on reducing reinfection post MDA: risk to self.
c) Quantify environmental force-of-infection and the impact of ‘risk to self’ and ‘risk to
|
Uganda |
2025-03-25 11:11:44 |
2028-03-25 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Riley Derby Nicholas
ID: UNCST-2025-R017680
|
Impacts of early social life on social and physical development in mountain gorillas
REFNo: NS946ES
Study social and physical change in immature mountain gorillas in Bwindi Impenetrable National Park, in collaboration with Bwindi Gorilla Project, through combining behavioral, hormonal, and non-invasive growth measures
|
USA |
2025-03-25 11:02:11 |
2028-03-25 |
Natural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Erika Sininärhi
ID: UNCST-2025-R017295
|
Physiological correlates of variation in personality traits in the banded
mongoose Mungos mungo
REFNo: NS942ES
1) To determine the relationship between social rank, prenatal androgen exposure, and personality.
2) To investigate whether individual differences in facial thermal patterns are connected to personality, behaviour and stress reactivity.
|
Finland |
2025-03-25 11:01:27 |
2028-03-25 |
Natural Sciences |
Non-Clinical Trial |
Degree Award |
|
David Hayman T. S.
ID: UNCST-2023-R006403
|
One Health, multiple factors: an interdisciplinary investigation of emerging infectious disease
REFNo: NS924ES
Infectious diseases significantly impact global health, affecting both humans and animals. Zoonotic diseases, which are transmitted between animals and humans, pose particular risks in regions with high human-wildlife interaction. One such region is Uganda, specifically around Bwindi Impenetrable National Park (BINP), where communities live in close proximity to domestic and wild animals.
The objectives of this research are to:
Identify and quantify zoonotic pathogens in fecal samples from various animal species.
Assess pathogen prevalence across different species.
Analyze microbial community structures and antimicrobial resistance genes.
|
New Zealand |
2025-03-25 11:00:19 |
2028-03-25 |
Natural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|